PMC:7253235 / 27713-28605
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
961 | 358-366 | Species | denotes | patients | Tax:9606 |
962 | 433-441 | Species | denotes | patients | Tax:9606 |
963 | 169-177 | Disease | denotes | COVID-19 | MESH:C000657245 |
964 | 273-291 | Disease | denotes | cardiac toxicities | MESH:D066126 |
965 | 424-432 | Disease | denotes | COVID-19 | MESH:C000657245 |
966 | 534-550 | Disease | denotes | cardiotoxicities | MESH:D066126 |
967 | 704-726 | Disease | denotes | cardiovascular disease | MESH:D002318 |
968 | 734-740 | Disease | denotes | cancer | MESH:D009369 |
969 | 867-875 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T287 | 169-177 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T288 | 424-432 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T289 | 704-726 | Disease | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/MONDO_0004995 |
T290 | 734-759 | Disease | denotes | cancer-related conditions | http://purl.obolibrary.org/obo/MONDO_0045054 |
T291 | 734-740 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
T292 | 867-875 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T198 | 403-404 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T199 | 670-678 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | actively |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T52 | 67-77 | Chemical | denotes | antivirals | http://purl.obolibrary.org/obo/CHEBI_22587 |
T53 | 296-300 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T54 | 301-305 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T161 | 349-357 | Phenotype | denotes | oncology | http://purl.obolibrary.org/obo/HP_0002664 |
T162 | 704-726 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
T163 | 734-740 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
T164 | 805-813 | Phenotype | denotes | oncology | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T179 | 0-178 | Sentence | denotes | Multiple treatments are being assessed in various trials including antivirals, anti-inflammatories, immunotherapies, and cardiovascular medications for the treatment of COVID-19. |
T180 | 179-484 | Sentence | denotes | Although some these therapies have potential to provide benefit, there are numerous potential cardiac toxicities and drug-drug interactions that may be harmful to cardio-oncology patients, which is critically relevant since a high percentage of COVID-19 patients have cardiovascular comorbidities [65–68]. |
T181 | 485-644 | Sentence | denotes | An appraisal of these agents and their potential cardiotoxicities—of which there is no current proven efficacy at this time—is beyond the scope of this review. |
T182 | 645-892 | Sentence | denotes | However, some agents are actively used in the treatment of cardiovascular disease and/or cancer-related conditions, and the unique disease states of the cardio-oncology population may yield insights into the mechanisms of COVID-19 pathophysiology. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32462289-27400984-24380957 | 477-479 | 27400984 | denotes | 65 |
32462289-30400791-24380957 | 477-479 | 30400791 | denotes | 65 |
32462289-22591294-24380957 | 477-479 | 22591294 | denotes | 65 |
32462289-10848718-24380957 | 477-479 | 10848718 | denotes | 65 |